These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 10873979)

  • 1. Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients.
    Waldock A; Snape J; Graham CM
    Br J Ophthalmol; 2000 Jul; 84(7):710-3. PubMed ID: 10873979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of timolol and latanoprost on respiratory and cardiovascular status in elderly patients with glaucoma.
    Ergin A; Ornek K; Güllü R; Bulcun E; Ekici M; Ekici A
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):463-6. PubMed ID: 19552600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The short-term effect of adding brimonidine 0.2% to timolol treatment in patients with open-angle glaucoma.
    Yüksel N; Altintaş O; Karabaş L; Alp B; Cağlar Y
    Ophthalmologica; 1999; 213(4):228-33. PubMed ID: 10420106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of latanoprost and betaxolol on cardiovascular and respiratory status of newly diagnosed glaucoma patients.
    Erkin EF; Celik P; Kayikçioğlu O; Deveci HM; Sakar A
    Ophthalmologica; 2006; 220(5):332-7. PubMed ID: 16954712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
    Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
    Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA
    Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials.
    van der Valk R; Webers CA; Schouten JS; Zeegers MP; Hendrikse F; Prins MH
    Ophthalmology; 2005 Jul; 112(7):1177-85. PubMed ID: 15921747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spirometry for patients prescribed topical beta-blockers.
    Snape JP; Waldock A
    Nurs Stand; 2000 Oct 11-17; 15(4):35-8. PubMed ID: 11971492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
    Nordmann JP; Söderström M; Rouland JF; Malecaze F
    Br J Ophthalmol; 2000 Feb; 84(2):181-5. PubMed ID: 10655195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
    Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the clinical success and quality-of-life impact of brimonidine 0.2% and betaxolol 0.25 % suspension in patients with elevated intraocular pressure.
    Cantor LB; Hoop J; Katz LJ; Flartey K;
    Clin Ther; 2001 Jul; 23(7):1032-9. PubMed ID: 11519768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of betaxolol on primary open-angle glaucoma and normal-tension glaucoma patients.
    Saccà SC; Macrì A; Rolando M; Ciurlo G
    J Ocul Pharmacol Ther; 1998 Jun; 14(3):191-201. PubMed ID: 9671427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short term study of the additive effect of timolol and brimonidine on intraocular pressure.
    Arici MK; Sayici M; Toker M; Erdoğan H; Topalkara A
    Eye (Lond); 2002 Jan; 16(1):39-43. PubMed ID: 11913886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular pressure reduction with topically administered pilocarpine, timolol and betaxolol in normal tension glaucoma.
    Nyman K
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):686-90. PubMed ID: 8109215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of various topical anti glaucoma drugs on cardiopulmonary system. A prospective study.
    Litoriya A; Tiwari US; Pathak R
    Rom J Ophthalmol; 2019; 63(2):142-145. PubMed ID: 31334392
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
    Greenfield DS; Liebmann JM; Ritch R
    J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma.
    Poinoosawmy D; Indar A; Bunce C; Garway-Heath DF; Hitchings RA
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):721-6. PubMed ID: 12271368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.